Genenta Science (GNTA) Institutional Ownership $3.76 -0.09 (-2.34%) As of 10:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Genenta Science (NASDAQ:GNTA)CurrentInstitutional OwnershipPercentage15.13%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$1.84MNumber ofInstitutional Sellers(last 12 months)0 Get GNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Genenta Science stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GNTA Institutional Buying and Selling by Quarter Genenta Science Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/9/2025Allianz SE233,550$927K0.0%+126.2%1.277% 5/8/2025Algebris UK Ltd100,000$368K0.1%+122.2%0.547% 2/17/2025Citadel Advisors LLC11,167$46K0.0%N/A0.061% 2/12/2025Allianz SE103,250$444K0.0%N/A0.565% 8/15/2024AlTi Global Inc.200,288$621K0.0%N/A1.099% 7/24/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 7/20/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 2/13/2023Algebris UK Ltd45,000$242K0.1%N/A0.247% (Data available from 1/1/2016 forward) GNTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GNTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Genenta Science shares: Bank Julius Baer & Co. Ltd Zurich ($2.46M), Allianz SE ($927K), AlTi Global Inc. ($621K), and Algebris UK Ltd ($368K), Citadel Advisors LLC ($46K).Learn more on Genenta Science's institutional investors. What percentage of Genenta Science's stock is owned by institutional investors? 15.13% of Genenta Science's stock is owned by institutional investors. Learn more on GNTA's institutional investor holdings. Which institutional investors have been buying Genenta Science's stock? The following institutional investors have purchased Genenta Science's stock in the last 24 months: Bank Julius Baer & Co. Ltd Zurich ($825.09K), Allianz SE ($233.55K), AlTi Global Inc. ($200.29K), Algebris UK Ltd ($55K), and Citadel Advisors LLC ($11.17K). How much institutional buying is happening at Genenta Science? Institutional investors have bought a total of 500,005 shares in the last 24 months. This purchase volume represents approximately $1.84M in transactions. Related Companies Entrada Therapeutics Institutional Ownership Corvus Pharmaceuticals Institutional Ownership Palvella Therapeutics Institutional Ownership 2seventy bio Institutional Ownership Tonix Pharmaceuticals Institutional Ownership Allogene Therapeutics Institutional Ownership Inozyme Pharma Institutional Ownership Aldeyra Therapeutics Institutional Ownership Candel Therapeutics Institutional Ownership Aurora Cannabis Institutional Ownership This page (NASDAQ:GNTA) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNTA Stock Alerts